Ogert, R. A., Howe, J. A., Vierling, J. M., Kwo, P. Y., Lawitz, E. J., McCone, J., Schiff, E. R., Pound, D., Davis, M. N., Gordon, S. C., Ravendhran, N., Rossaro, L., Jacobson, I. M., Ralston, R., Chaudhri, E., Qiu, P., Pedicone, L. D., Brass, C. A., Albrecht, J. K., Barnard, R. J., Hazuda, D. J., & Howe, A. Y. (2013). resistance-Associated Amino Acid Variants Associated with Boceprevir plus Pegylated Interferon-α2B and Ribavirin in Patients with Chronic Hepatitis C in the Sprint-1 Trial. Antiviral therapy, 18(3), 387–397. http://access.bl.uk/ark:/81055/vdc_100170289043.0x00002a